| scholarly article | Q13442814 |
| P2093 | author name string | Ying Chen | |
| Tian Xia | |||
| Xiaodong Jiao | |||
| Keping Xie | |||
| Suyun Huang | |||
| Guanzhen Yu | |||
| Yunshu Gao | |||
| Jiejun Wang | |||
| Zhaosheng Li | |||
| Wenzheng Fang | |||
| P2860 | cites work | Abnormal glucose tolerance and the risk of cancer death in the United States | Q44471360 |
| Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer | Q46119167 | ||
| AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. | Q48302574 | ||
| Targeting AMPK in the treatment of malignancies | Q53218614 | ||
| Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | Q53641389 | ||
| Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer | Q60398030 | ||
| Studies on gastric lymphatics by using activated carbon particle (CH44) and lymph node metastasis of gastric cancer | Q68492229 | ||
| Lymph node metastasis in early gastric cancer | Q68961406 | ||
| [A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy] | Q69258325 | ||
| Surgical approach to early gastric cancer with lymph node metastasis | Q69359385 | ||
| Clinicopathologic studies of gastric cancer with metastasis to the liver--based on the cases detected at initial surgery | Q71304389 | ||
| Extended indication criteria for endoscopic mucosal resection of early gastric cancer with special reference to lymph node metastasis--examination by multivariate analysis | Q80104091 | ||
| New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma | Q81121636 | ||
| Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer | Q81413248 | ||
| The Effect of Locoregional Transarterial Infusion Chemotherapy on Liver Metastasis after Gastric Cancer Resection | Q84828291 | ||
| Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy | Q85342526 | ||
| Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study | Q87418247 | ||
| [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism] | Q95501236 | ||
| AMP-activated protein kinase: a target for drugs both ancient and modern | Q26864424 | ||
| Metformin: a therapeutic opportunity in breast cancer | Q33733319 | ||
| Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals | Q33795313 | ||
| Long-term metformin use is associated with decreased risk of breast cancer. | Q33873130 | ||
| The influence of transforming growth factor‐α, cyclooxygenase‐2, matrix metalloproteinase (MMP)‐7, MMP‐9 and CXCR4 proteins involved in epithelial–mesenchymal transition on overall survival of patients with gastric cancer | Q34274752 | ||
| Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. | Q34786695 | ||
| Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. | Q34887704 | ||
| Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer | Q34984314 | ||
| Braveheart, a long noncoding RNA required for cardiovascular lineage commitment | Q36585810 | ||
| PTEN and the PI3-kinase pathway in cancer | Q37259680 | ||
| Genetic modelling of the PTEN/AKT pathway in cancer research | Q37305035 | ||
| Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis | Q37334587 | ||
| Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention | Q37608817 | ||
| Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena | Q37715626 | ||
| Metformin: its emerging role in oncology | Q37846987 | ||
| Diabetes mellitus and the risk of cancer. | Q37948495 | ||
| Management of Brain Metastasis: Past Lessons, Modern Management, and Future Considerations | Q37954518 | ||
| Metformin and cancer therapy. | Q37962127 | ||
| Denosumab for the Prevention of Skeletal‐Related Events in Patients with Bone Metastasis from Solid Tumor | Q37990849 | ||
| Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: Evidence for survivin acting as a transcription factor or co-factor | Q39364694 | ||
| The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo | Q39416862 | ||
| Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. | Q39727746 | ||
| AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells | Q39733339 | ||
| Decorin suppresses lung metastases of murine osteosarcoma | Q39979575 | ||
| Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial | Q42920181 | ||
| AMP-activated protein kinase (AMPK) as a potential therapeutic target independent of PI3K/Akt signaling in prostate cancer. | Q43091920 | ||
| A case of metastasis from gastric cancer to the thyroid gland | Q43696385 | ||
| Morphology, immunohistochemistry and hTERC gene in-situ hybridization in Barrett's esophagus | Q43885898 | ||
| Tumour suppressor gene expression correlates with gastric cancer prognosis | Q44401645 | ||
| Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study | Q44453199 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| sirolimus | Q32089 | ||
| cisplatin | Q412415 | ||
| P304 | page(s) | 12748-12762 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Metformin potentiates rapamycin and cisplatin in gastric cancer in mice | |
| P478 | volume | 6 |
| Q61810575 | Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma |
| Q92645973 | CDX1 Expression Induced by CagA-Expressing Helicobacter pylori Promotes Gastric Tumorigenesis |
| Q42061952 | Celastrol induces cell cycle arrest by MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in gastric cancer |
| Q38818730 | Combinational strategies of metformin and chemotherapy in cancers |
| Q38715697 | Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line. |
| Q33829205 | From rapalogs to anti-aging formula |
| Q36546520 | Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression |
| Q58699189 | Metformin and blood cancers |
| Q37688014 | Metformin and cancer: Quo vadis et cui bono? |
| Q49658205 | Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway |
| Q58733981 | Metformin inhibits ovarian cancer growth and migration in vitro and in vivo by enhancing cisplatin cytotoxicity |
| Q37708932 | Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway |
| Q37274957 | Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus |
| Q89158246 | Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism |
| Q97542974 | Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma |
| Q37644891 | Metformin use and cervical cancer risk in female patients with type 2 diabetes |
| Q49183232 | Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies |
| Q90575454 | Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study |
| Q36292690 | PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma |
| Q42365321 | Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin |
| Q38819571 | Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma |
| Q38826019 | SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma |
| Q38375735 | Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours |
| Q38728567 | The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development |
| Q38744613 | The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma |
Search more.